Clinical trial
Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and…
NCT00209625 · Hokkaido Gastrointestinal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00209625 |
|---|---|
| Title | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer |
| Official title | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer：Hokkaido Gastrointestinal Cancer Study Group:HGCSG0001 |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | irinotecan, leucovorin, fluorouracil |
| Enrollment | 23 |
| Start date | Apr 1, 2000 |
| Completion | Nov 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: